Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
1(33%)
Results Posted
0%(0 trials)
Terminated
1(33%)

Phase Distribution

Ph phase_1
1
33%
Ph not_applicable
2
67%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
Phase 1Safety & dosage
1(33.3%)
N/ANon-phased studies
2(66.7%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Completed(1)
Terminated(1)

Detailed Status

Completed1
Terminated1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
50.0%
Most Advanced
Phase 1

Trials by Phase

Phase 11 (33.3%)
N/A2 (66.7%)

Trials by Status

completed133%
terminated133%
active_not_recruiting133%

Recent Activity

1 active trials
Showing 3 of 3
active_not_recruitingnot_applicable

Cola Ingestion for Esophageal Bolus Impaction

NCT06652620
terminatedphase_1

Influence of an Acidic Beverage on the Imatinib Exposure After Major Gastrectomy

NCT02185937
completednot_applicable

Sugars-sweetened Commercial Beverages on Short-term Food Intake

NCT01717703

Clinical Trials (3)

Showing 3 of 3 trials
NCT06652620Not Applicable

Cola Ingestion for Esophageal Bolus Impaction

Active Not Recruiting
NCT02185937Phase 1

Influence of an Acidic Beverage on the Imatinib Exposure After Major Gastrectomy

Terminated
NCT01717703Not Applicable

Sugars-sweetened Commercial Beverages on Short-term Food Intake

Completed

All 3 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
3